This is an extended version of the interview with researchers at Harvard and the University of Massachusetts, which indicates that out in the real world, people who use nicotine replacement therapy in the hopes of an easier “quit” don’t fare any better than people who use will power and community support. Some people who use nicotine replacements are actually MORE likely to relapse. Here, Shelley Schlender talks with Lois Biener, a Senior Research Fellow at the Center for Survey Research at the University of Massachusetts Boston. Her research was published in the journal Tobacco Control.
Podcast: Play in new window | Download (Duration: 7:34 — 10.4MB)
Subscribe: RSS
Nicotine is an alkaloid found in the nightshade family of plants (”Solanaceae”) which constitutes approximately 0.6–3.0% of dry weight of tobacco, with biosynthesis taking place in the roots, and accumulating in the leaves. It functions as an antiherbivore chemical with particular specificity to insects; therefore nicotine was widely used as an insecticide in the past, and currently nicotine analogs such as imidacloprid continue to be widely used.-”*
Catch ya later
http://www.healthmedicinedigest.comxxxxxxx-PLEASE-REMOVE-THE-X'S-AFTER-OUR-WEBSITE-LINK-AND-ALSO-THIS-MESSAGE-BY-CLICKING-QUICK-EDIT-IF-YOU-FIND-THIS-BLOG-COMMENT-USEFUL-THANK-YOU-